Stay updated on Nivolumab in Advanced Squamous Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced Squamous Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab in Advanced Squamous Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe Nivolumab phase 2 study record for advanced or metastatic squamous non-small-cell lung cancer is displayed with its completed status, participant criteria, study locations, treatment plan, and outcome measures. The record also includes study dates, publications, and links to related drug and trial information.SummaryDifference56%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA sitewide NIH banner about the terminology transition was added, and the displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previously visible study record content and navigation; this indicates the detailed information about the study is no longer accessible on this page.SummaryDifference17%

- Check59 days agoChange DetectedRevision metadata on the page was updated from v3.6.6 to v3.7.0, indicating a newer version of the study record.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Advanced Squamous Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced Squamous Lung Cancer Clinical Trial page.